Charles Schwab Investment Management Inc Exagen Inc. Transaction History

Charles Schwab Investment Management Inc

  • $429 Billion
  • Q1 2024

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2022

Aug 15, 2022
SELL
$4.18 - $7.74 $113,169 - $209,552
-27,074 Closed
0 $0
Q2 2021

Aug 16, 2021
BUY
$12.4 - $17.92 $208,580 - $301,432
16,821 Added 164.06%
27,074 $406,000
Q2 2020

Aug 14, 2020
BUY
$11.0 - $16.7 $112,783 - $171,225
10,253 New
10,253 $128,000

Others Institutions Holding XGN

# of Institutions
35
Shares Held
6.21M
Call Options Held
1.6K
Put Options Held
4.1K
View Full List

About EXAGEN INC.

XGN Quotes by TradingView
  • Ticker XGN
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Diagnostics & Research
  • Shares Outstandng 16,260,400
  • Market Cap $28.9M
  • Description
  • Exagen Inc. develops and commercializes various testing products based on its cell-bound complement activation products technology under the AVISE brand in the United States. It enables rheumatologists to care for patients through the diagnosis, prognosis, and monitoring of autoimmune and autoimmune-related diseases, including systemic lupus ery...
More about XGN
Track This Portfolio

Track Charles Schwab Investment Management Inc Portfolio

Follow Charles Schwab Investment Management Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Charles Schwab Investment Management Inc, based on Form 13F filings with the SEC.

News

Stay updated on Charles Schwab Investment Management Inc with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email